share_log

GlaxoSmithKline | 6-K: Gsk Delivers Strong 2023 Performance and Upgrades Growth Outlooks

SEC ·  Feb 1 02:02
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.